Skip to content

Key Issues in 2003 Generic Medicine Petition Highlighted in Court

By News Analysis India · · 1 min read

Lawyer Kisan Chand Jain reiterated that the 2003 petition raises two critical concerns. First, it seeks a directive that every registered medical practitioner issue prescriptions for generic drugs, thereby improving accessibility and affordability.

Second, it challenges the existing framework for determining a drug's MRP. While schedule medicines are regulated by the National Pharmaceutical Pricing Authority with a statutory 16 percent retailer margin, non‑schedule drugs remain largely unregulated, permitting manufacturers to set disproportionately high MRPs.

Jain cited examples where a product available in the market for ₹10 is listed with an MRP of ₹100, creating a financial burden for patients, especially in hospitals that calculate charges on the basis of MRP. Even when reimbursements are promised by the government, the inflated MRPs can lead to higher outlays.

The court noted the need to reconsider the practice of adding a fixed retailer margin when fixing MRPs and emphasized that price control remains a long‑standing judicial concern. The next date for argument has been fixed for 5 October.